Back to results
US 2026/0274472 A1Published application
Method of production
AssigneeNovartis AG
InventorGeert Vandenbossche
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a method of producing a packaged radiopharmaceutical drug product by operating the different manufacturing steps including inspection in various cold and shielded units of cleanliness zoning requirements of Grade A, B, C, or CNC. It further relates to the manufacturing units comprising technical equipment required for said method, the drug product obtained by said method, as well as its technical and medical use.
Claims21
A method for producing a packaged radiopharmaceutical drug product (e.g. a radioligand drug product) comprising the steps of:
- (1) Synthesizing and compounding a radiopharmaceutical drug substance solution in one or more shielded units of (cleanliness zoning requirement) Grade C to obtain a radiopharmaceutical drug product;
- (2) Providing primary packaging materials, e.g. by (outer-layer-)unpacking in one or more cold units of Grade C, sanitizing in one or more cold units of Grade B, and (inner-layer-)unpacking said packaging materials in one or more cold units of Grade A;
- (3) Filling the radiopharmaceutical drug substance solution obtained by step (1) into the primary packaging materials as provided and unpacked by step (2) in a shielded unit of Grade A to obtain the primarily packaged radiopharmaceutical drug product;
- (4) Inspecting the primarily packaged radiopharmaceutical drug product obtained by step (3) in one or more shielded units of Grade “Controlled, non-classified” (CNC);
- and
- (5) optionally, placing the primarily packaged radiopharmaceutical drug product as inspected by step (4) into a shielded secondary packaging material in one or more shielded units of Grade CNC to obtained a primarily and secondarily packaged radiopharmaceutical drug product.
3 more elements
Dependencies are inferred from the claim text.